HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Stem Cell Research and Regeneration on Cardiology
Stem Cell Research and Regeneration on Cardiology
Stem Cell Research: Stem-cell research is a research that involves the properties of stem cells and their potential utilize in medicine. Stem cells are the origin of all tissues, describing their properties helps in our understanding of the healthy and diseased body's development and homeostasis.There are five different types of stem cells discussed;
- Totipotent (or Omnipotent) Stem Cells
- Pluripotent Stem Cells
- Multipotent Stem Cells
- Oligopotent Stem Cells
- Unipotent Stem Cells
Regeneration on Cardiology: Cardiac regeneration is a wide attempt that straight to repair inevitably harmed heart tissue with cutting-edge science, involving stem cell and cell-free therapy. Many tools have been developed to replace injured heart tissue and impaired heart function using the body's natural ability to regenerate.
Committee Members
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States Cardio 2026 Speakers
Mekhman N Mamedov
National Research Center for Therapy and Preventive Medicine, Russian Federation
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain